News
Archive: May 2024
IXICO to support on Global Alzheimer's Platform Foundation's Bio-Hermes 2 trial
IXICO plc (AIM: IXI), the medical imaging advanced analytics company delivering insights in neuroscience announces that it has signed a contract with the Global Alzheimer's Platform Foundation® ("GAP") to support GAP's planned Bio-Hermes 2 trial. The contract value is worth over £1 million over a 48-month term.